BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8104616)

  • 1. Autologous transfusion requirements in bone marrow harvest: results of the ATREMA study.
    Valentini CG; Innocenti I; Pellegrino C; Draisci G; Teofili L;
    Blood Transfus; 2024 Jan; 22(1):90-92. PubMed ID: 38276912
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcome of peripheral blood stem cell support.
    Kessinger A; Armitage J; Bierman P; Bishop M; Joshi S; Reed E; Sharp G; Talmadge J; Vose J
    Med Oncol; 1994; 11(2):43-6. PubMed ID: 7850263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood stem cell transfusion for marrow replacement.
    Morse EE; Dainiak N; Sorba S; King C; Gaffney J; Ascensao JL
    Ann Clin Lab Sci; 1992; 22(4):221-5. PubMed ID: 1380224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is blood or bone marrow better?
    Kessinger A
    Stem Cells; 1993 Jul; 11(4):290-5. PubMed ID: 8104616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is our current strategy in manipulating hemopoiesis in autologous transplantation correct?
    To LB
    Stem Cells; 1993 Jul; 11(4):283-9. PubMed ID: 8104615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of peripheral stem cell support of high-dose chemotherapy.
    Kessinger A; Armitage JO
    Important Adv Oncol; 1993; ():167-75. PubMed ID: 8099339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
    Siena S; Bregni M; Bonsi L; Strippoli P; Peccatori F; Magni M; Di Nicola M; Bagnara GP; Massimo Gianni A
    Stem Cells; 1993 Jul; 11 Suppl 2():72-5. PubMed ID: 8104618
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.